Fayez Sarofim & CO Novo Nordisk A S Transaction History
Fayez Sarofim & CO
- $38.8 Billion
- Q1 2025
A detailed history of Fayez Sarofim & CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Fayez Sarofim & CO holds 11,212,499 shares of NVO stock, worth $790 Million. This represents 2.01% of its overall portfolio holdings.
Number of Shares
11,212,499
Previous 11,384,481
1.51%
Holding current value
$790 Million
Previous $979 Million
20.49%
% of portfolio
2.01%
Previous 2.46%
Shares
31 transactions
Others Institutions Holding NVO
# of Institutions
1,768Shares Held
330MCall Options Held
11.3MPut Options Held
15.5M-
Jennison Associates LLC18.8MShares$1.33 Billion0.93% of portfolio
-
Bank Of America Corp Charlotte, NC14.8MShares$1.04 Billion0.08% of portfolio
-
Loomis Sayles & CO L P12.4MShares$873 Million1.24% of portfolio
-
Morgan Stanley New York, NY12.3MShares$868 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa11.9MShares$836 Million0.36% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $159B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...